Ann M Hoff

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Methadone use as a second-line agent for severe cancer-related pain is increasing in the field of hospice and palliative care. It has a number of qualities that make its use favorable, including lack of known active metabolites and presumed relative safety from adverse effects such as opioid-induced neurotoxicity (OIN). This article describes a case of a(More)
  • 1